Literature DB >> 8342233

Effect of storage time on clinical efficacy of single-donor platelet units.

M F Leach1, J P AuBuchon.   

Abstract

Decrements in platelet function and recovery are known to accumulate during the 5-day storage period, and the clinical response to platelets transfused after several days' storage has been suggested by some researchers to be less than that seen with platelets stored for shorter periods. The clinical response to single-donor platelet (SDP) units (as measured by corrected count increments [CCIs] and intertransfusion intervals) was investigated in autologous bone marrow transplant patients. Twenty-seven consecutive autologous bone marrow transplant patients with a variety of hematologic and solid organ malignancies were evaluated for posttransfusion CCIs after 419 SDP transfusions of units stored for 1 to 5 days. Patients were not excluded from the study because of clinical condition, such as fever or sepsis. The mean 15-minute posttransfusion CCI for SDP units stored for only 1 day (11,006 +/- 5,157) was no different than that for units stored for 5 days (10,225 +/- 4,481; p > 0.05); 24-hour posttransfusion CCIs were also not different if the SDP unit had been stored for 1 day or 5 days (6229 +/- 4489 vs. 4786 +/- 2759; p > 0.05) or for any intermediate period. Nor were intertransfusion intervals affected by storage time. While platelets may exhibit a progressive lesion during the 5-day storage period, these changes do not result in a decreased clinical response.

Entities:  

Mesh:

Year:  1993        PMID: 8342233     DOI: 10.1046/j.1537-2995.1993.33893342748.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

1.  Towards targeting platelet storage lesion-related signaling pathways.

Authors:  Peter Schubert; Dana V Devine
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

2.  HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients.

Authors:  Ashok Nambiar; Rene J Duquesnoy; Sharon Adams; Yingdong Zhao; Jaime Oblitas; Susan Leitman; David Stroncek; Francesco Marincola
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

3.  The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia.

Authors:  Darrell J Triulzi; Susan F Assmann; Ronald G Strauss; P M Ness; John R Hess; Richard M Kaufman; Suzanne Granger; Sherrill J Slichter
Journal:  Blood       Date:  2012-04-10       Impact factor: 22.113

4.  Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients.

Authors:  Sherrill J Slichter; Kathryn Davis; Helen Enright; Hayden Braine; Terry Gernsheimer; Kuo-Jang Kao; Thomas Kickler; Edward Lee; Janice McFarland; Jeffrey McCullough; Glenn Rodey; Charles A Schiffer; Robert Woodson
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.